Importer of Controlled Substances Application: Johnson Matthey Inc., 71766-71767 [2016-25126]
Download as PDF
<![CDATA[
71766
Federal Register / Vol. 81, No. 201 / Tuesday, October 18, 2016 / Notices
Stryker Corporation (‘‘complainant’’) of
Kalamazoo, Michigan. 81 FR 11590
(March 4, 2016). The complaint as
supplemented alleges violations of
Section 337 of the Tariff Act of 1930, as
amended, 19 U.S.C. 1337, in the sale for
importation, importation, or sale within
the United States after importation of
certain hospital beds, and components
thereof by reason of infringement of
certain claims of U.S. Patent No.
7,082,630; U.S. Patent No. 7,690,059
(‘‘the ’059 patent’’); U.S. Patent No.
7,784,125; and U.S. Patent No.
8,701,229 (‘‘the ’229 patent’’). The
complaint further alleges that an
industry in the United States exists as
required by subsection (a)(2) of section
337. The complaint names Umano
Medical Inc. of Quebec, Canada and
Umano Medical World Inc. of Quebec,
Canada as respondents. The Office of
Unfair Import Investigations is not a
party in the investigation.
On September 2, 2016, the parties
filed a joint motion to terminate the
investigation based on settlement. The
parties provided confidential and nonconfidential versions of the settlement
agreement and represented that there
are no other agreements, written or oral,
express or implied, between the Settling
Parties concerning the subject matter of
this Investigation.
On September 13, 2016, the ALJ
granted the joint motion. Order No. 10.
The ALJ found that all of the
requirements of Commission Rule
210.21(a)–(b), 19 CFR 210.21(a)–(b), had
been met and that there were no public
interest concerns that would weigh
against termination. No petitions for
review were filed.
The Commission has determined not
to review the subject ID.
The authority for the Commission’s
determination is contained in section
337 of the Tariff Act of 1930, as
amended (19 U.S.C. 1337), and in Part
210 of the Commission’s Rules of
Practice and Procedure (19 CFR part
210).
By order of the Commission.
Issued: October 12, 2016.
Lisa R. Barton,
Secretary to the Commission.
Lhorne on DSK30JT082PROD with NOTICES
[FR Doc. 2016–25094 Filed 10–17–16; 8:45 am]
BILLING CODE 7020–02–P
VerDate Sep<11>2014
13:19 Oct 17, 2016
Jkt 241001
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Anderson Brecon, Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic class, and applicants
therefore, may file written comments on
or objections to the issuance of the
proposed registration in accordance
with 21 CFR 1301.34(a) on or before
November 17, 2016. Such persons may
also file a written request for a hearing
on the application pursuant to 21 CFR
1301.43 on or before November 17,
2016.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/ODW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated her
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Deputy Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Deputy Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on June
10, 2016, Anderson Brecon, Inc., DBA
PCI of Illinois, 4545 Assembly Drive,
Rockford, Illinois 61109 applied to be
registered as an importer of oxycodone
(9143), a basic class of controlled
substance listed in schedule II.
ADDRESSES:
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
The company plans to import the
listed controlled substances in bulk
over-encapsulated tablets for clinical
trial only. Approval of permit
applications will occur only when the
registrant’s business activity is
consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization
will not extend to the import of FDA
approved or non-approved finished
dosage forms for commercial sale.
Dated: October 11, 2016.
Louis J. Milione,
Assistant Administrator, Diversion Control
Division.
[FR Doc. 2016–25131 Filed 10–17–16; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Johnson Matthey Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.34(a) on
or before November 17, 2016. Such
persons may also file a written request
for a hearing on the application
pursuant to 21 CFR 1301.43 on or before
November 17, 2016.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DRW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
Comments and request for hearings on
applications to import narcotic raw
material are not appropriate. 72 FR
3417, (January 25, 2007).
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated her
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
DATES:
E:\FR\FM\18OCN1.SGM
18OCN1
Federal Register / Vol. 81, No. 201 / Tuesday, October 18, 2016 / Notices
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on
September 5, 2016, Johnson Matthey
Inc., Pharmaceutical Materials, 2003
Nolte Drive, West Deptford, New Jersey
08066–1742, applied to be registered as
an importer of the following basic
classes of controlled substances:
Controlled substance
Coca Leaves ................
Thebaine .......................
Opium, raw ...................
Noroxymorphone ..........
Poppy Straw Concentrate.
Fentanyl ........................
Drug
code
Schedule
9040
9333
9600
9668
9670
II
II
II
II
II
9801
II
The company plans to import
Thebaine derivatives and Fentanyl as
reference standards. The company plans
to import the remaining listed
controlled substances as raw materials,
to be used in the manufacture of bulk
controlled substances, for distribution to
its customers.
Dated: October 11, 2016.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2016–25126 Filed 10–17–16; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Johnson
Matthey Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before December 19, 2016.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Lhorne on DSK30JT082PROD with NOTICES
DATES:
VerDate Sep<11>2014
13:19 Oct 17, 2016
Jkt 241001
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
The
Attorney General has delegated her
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on
September 5, 2016, Johnson Matthey
Inc., Custom Pharmaceuticals
Department, 2003 Nolte Drive, West
Deptford, New Jersey 08066–1742
applied to be registered as a bulk
manufacturer the following basic classes
of controlled substances:
SUPPLEMENTARY INFORMATION:
Controlled Substance
Gamma Hydroxybutyric
Acid.
Marihuana .....................
Tetrahydrocannabinols
Dihydromorphine ..........
Difenoxin .......................
Propiram .......................
Amphetamine ...............
Methamphetamine ........
Lisdexamfetamine ........
Methylphenidate ...........
Nabilone .......................
Cocaine ........................
Codeine ........................
Dihydrocodeine .............
Oxycodone ...................
Hydromorphone ............
Diphenoxylate ...............
Ecgonine .......................
Hydrocodone ................
Meperidine ....................
Methadone ....................
Methadone intermediate
Morphine .......................
Thebaine .......................
Oxymorphone ...............
Noroxymorphone ..........
Alfentanil .......................
Remifentanil ..................
Sufentanil ......................
Tapentadol ....................
Fentanyl ........................
PO 00000
Frm 00079
Fmt 4703
Drug
code
Schedule
2010
I
7360
7370
9145
9168
9649
1100
1105
1205
1724
7379
9041
9050
9120
9143
9150
9170
9180
9193
9230
9250
9254
9300
9333
9652
9668
9737
9739
9740
9780
9801
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
Sfmt 4703
71767
The company plans to manufacture
the listed controlled substances in bulk
for sale to its customers.
In reference to drug codes 7360
(marihuana) and 7370 (THC), the
company plans to bulk manufacture
these drugs as synthetics. No other
activities for these drug codes are
authorized for this registration.
Dated: October 11, 2016.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2016–25133 Filed 10–17–16; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF LABOR
Wage and Hour Division
Agency Information Collection
Activities; Comment Request;
Information Collections: Report of
Construction Contractor’s Wage Rates
Wage and Hour Division,
Department of Labor.
ACTION: Notice.
AGENCY:
The Department of Labor
(DOL) is soliciting comments
concerning a proposed extension of the
information collection request (ICR)
titled, ‘‘Report of Construction
Contractor’s Wage Rates.’’ This
comment request is part of continuing
Departmental efforts to reduce
paperwork and respondent burden in
accordance with the Paperwork
Reduction Act of 1995 (PRA), 44 U.S.C.
3501 et seq.
This program helps to ensure that
requested data can be provided in the
desired format, reporting burden (time
and financial resources) is minimized,
collection instruments are clearly
understood, and the impact of collection
requirements on respondents can be
properly assessed. A copy of the
proposed information request can be
obtained by contacting the office listed
below in the FOR FURTHER INFORMATION
CONTACT section of this Notice.
DATES: Written comments must be
submitted to the office listed in the
ADDRESSES section below on or before
December 19, 2016.
ADDRESSES: You may submit comments
identified by Control Number 1235–
0015, by either one of the following
methods: Email: WHDPRAComments@
dol.gov; Mail, Hand Delivery, Courier:
Division of Regulations, Legislation, and
Interpretation, Wage and Hour, U.S.
Department of Labor, Room S–3502, 200
Constitution Avenue NW., Washington,
DC 20210. Instructions: Please submit
one copy of your comments by only one
SUMMARY:
E:\FR\FM\18OCN1.SGM
18OCN1
]]>Agencies
[Federal Register Volume 81, Number 201 (Tuesday, October 18, 2016)]
[Notices]
[Pages 71766-71767]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-25126]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Application: Johnson Matthey
Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.34(a) on or before November 17, 2016. Such persons may also file a
written request for a hearing on the application pursuant to 21 CFR
1301.43 on or before November 17, 2016.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DRW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive,
Springfield, Virginia 22152. Comments and request for hearings on
applications to import narcotic raw material are not appropriate. 72 FR
3417, (January 25, 2007).
SUPPLEMENTARY INFORMATION: The Attorney General has delegated her
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to
[[Page 71767]]
exercise all necessary functions with respect to the promulgation and
implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Office of Diversion Control
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.34(a), this is notice that on
September 5, 2016, Johnson Matthey Inc., Pharmaceutical Materials, 2003
Nolte Drive, West Deptford, New Jersey 08066-1742, applied to be
registered as an importer of the following basic classes of controlled
substances:
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Coca Leaves............................ 9040 II
Thebaine............................... 9333 II
Opium, raw............................. 9600 II
Noroxymorphone......................... 9668 II
Poppy Straw Concentrate................ 9670 II
Fentanyl............................... 9801 II
------------------------------------------------------------------------
The company plans to import Thebaine derivatives and Fentanyl as
reference standards. The company plans to import the remaining listed
controlled substances as raw materials, to be used in the manufacture
of bulk controlled substances, for distribution to its customers.
Dated: October 11, 2016.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2016-25126 Filed 10-17-16; 8:45 am]
BILLING CODE 4410-09-P
